<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="than 1,500 papers on COVID-19 available in the PubMed and" exact="China" post="National Knowledge Infrastructure databases from January 1, 2020 to"/>
 <result pre="JAMA, BMJ, Springer Nature, National Medical Journal of China, and" exact="China" post="Biotechnology set up a special hub to support the"/>
 <result pre="prognosis, nursing, prevention, and control, were available in PubMed and" exact="China" post="National Knowledge Infrastructure (CNKI)databases. In this review, the global"/>
 <result pre="February, by more than 2.5 times. This may be because" exact="China" post="was the most severely affected country in the early"/>
 <result pre="is positively correlated with the severity in that particular country." exact="China" post="was one of the most severely affected countries in"/>
 <result pre="therefore, COVID-19-related studies were carried out rapidly. As a result," exact="China" post="(including Hong Kong, Macao, and Taiwan) ranked no. 1"/>
 <result pre="studies were carried out rapidly. As a result, China (including" exact="Hong Kong," post="Macao, and Taiwan) ranked no. 1 with 353 published"/>
 <result pre="recent experience in the prevention and control of seasonal influenza," exact="the US" post="ranked second, with 97 published studies related to COVID-19."/>
 <result pre="to COVID-19. European countries, such as the UK (27 papers)," exact="Germany" post="(15 papers) and Italy (15 papers) were among the"/>
 <result pre="such as the UK (27 papers), Germany (15 papers) and" exact="Italy" post="(15 papers) were among the countries with the highest"/>
 <result pre="focus of COVID-19 studies has varied across different regions worldwide." exact="China" post="has mainly focused on the epidemiology of COVID-19. Patients"/>
 <result pre="characteristics and biochemical markers of COVID-19.6 A research foundation in" exact="Hong Kong," post="with 26 articles on SARS, rapidly initiated studies on"/>
 <result pre="effective control of the spread of COVID-19. Research institutions in" exact="Hong Kong" post="include universities (such as the University of Hong Kong,"/>
 <result pre="in Hong Kong include universities (such as the University of" exact="Hong Kong," post="Hong Kong Polytechnic University) as well as hospitals (such"/>
 <result pre="Kong include universities (such as the University of Hong Kong," exact="Hong Kong" post="Polytechnic University) as well as hospitals (such as the"/>
 <result pre="as preventative and control measures for COVID-19.7,8 The Government of" exact="Macau" post="has placed greater emphasis on studies related to the"/>
 <result pre="against transmission of COVID-19. Furthermore, studies performed by hospitals, in" exact="Taiwan" post="(nine papers) (such as the National Taiwan University College"/>
 <result pre="by hospitals, in Taiwan (nine papers) (such as the National" exact="Taiwan" post="University College of Medicine and regional general hospitals), have"/>
 <result pre="on routes of transmission and clinical characteristics of COVID-19.9 In" exact="the US," post="considerable studies on the epidemiology (30 papers), prevention and"/>
 <result pre="be undertaken at different phases of epidemic development. Research in" exact="Canada" post="has focused on the epidemiology of COVID-19, such as"/>
 <result pre="University of Toronto about the transmission dynamics and risk assessment." exact="Japan" post="has placed significant emphasis on epidemiological studies, with studies"/>
 <result pre="epidemiological studies, with studies published by Hokkaido University and the" exact="Japan" post="Science and Technology Agency describing the incubation period of"/>
 <result pre="describing the incubation period of SARS-CoV-2 and quarantine duration. Similarly," exact="Germany" post="has mainly focused on epidemiological studies; for example, Heidelberg"/>
 <result pre="SARS-CoV-2 and predict its transmission dynamics and impact. Studies in" exact="Italy" post="have placed a relatively higher focus on the epidemiological"/>
 <result pre="research projects for the prevention and control of the epidemic." exact="China" post="has collaborated with 21 countries, including the US, Canada,"/>
 <result pre="of the epidemic. China has collaborated with 21 countries, including" exact="the US," post="Canada, and Japan, and published 80 related articles on"/>
 <result pre="dominating COVID-19 research. Furthermore, collaborative networks have been established among" exact="the US," post="Europe, and Southeast Asia as well as within European"/>
 <result pre="line. Table 1 Number of Publications Resulting from Collaborations between" exact="China" post="and Collaborative Countries, by Research Subdomain Etiology Diagnosis Epidemiology"/>
 <result pre="Nursing Prevention and Control US (9) US (4) US (11)" exact="Japan" post="(3) Canada (1) Canada (2) US (8) Japan (2)"/>
 <result pre="and Control US (9) US (4) US (11) Japan (3)" exact="Canada" post="(1) Canada (2) US (8) Japan (2) UK (1)"/>
 <result pre="US (9) US (4) US (11) Japan (3) Canada (1)" exact="Canada" post="(2) US (8) Japan (2) UK (1) Saudi Arabia"/>
 <result pre="US (11) Japan (3) Canada (1) Canada (2) US (8)" exact="Japan" post="(2) UK (1) Saudi Arabia (2) US (1) Australia"/>
 <result pre="Canada (1) Canada (2) US (8) Japan (2) UK (1)" exact="Saudi Arabia" post="(2) US (1) Australia (1) Australia (2) Australia (1)"/>
 <result pre="(8) Japan (2) UK (1) Saudi Arabia (2) US (1)" exact="Australia" post="(1) Australia (2) Australia (1) Germany (1) Japan (2)"/>
 <result pre="(2) UK (1) Saudi Arabia (2) US (1) Australia (1)" exact="Australia" post="(2) Australia (1) Germany (1) Japan (2) Italy (1)"/>
 <result pre="(1) Saudi Arabia (2) US (1) Australia (1) Australia (2)" exact="Australia" post="(1) Germany (1) Japan (2) Italy (1) Canada (2)"/>
 <result pre="Arabia (2) US (1) Australia (1) Australia (2) Australia (1)" exact="Germany" post="(1) Japan (2) Italy (1) Canada (2) Austria (1)"/>
 <result pre="US (1) Australia (1) Australia (2) Australia (1) Germany (1)" exact="Japan" post="(2) Italy (1) Canada (2) Austria (1) Japan (1)"/>
 <result pre="Australia (1) Australia (2) Australia (1) Germany (1) Japan (2)" exact="Italy" post="(1) Canada (2) Austria (1) Japan (1) Italy (2)"/>
 <result pre="Australia (2) Australia (1) Germany (1) Japan (2) Italy (1)" exact="Canada" post="(2) Austria (1) Japan (1) Italy (2) Bangladesh (1)"/>
 <result pre="Australia (1) Germany (1) Japan (2) Italy (1) Canada (2)" exact="Austria" post="(1) Japan (1) Italy (2) Bangladesh (1) Germany (1)"/>
 <result pre="Germany (1) Japan (2) Italy (1) Canada (2) Austria (1)" exact="Japan" post="(1) Italy (2) Bangladesh (1) Germany (1) Switzerland (1)"/>
 <result pre="Japan (2) Italy (1) Canada (2) Austria (1) Japan (1)" exact="Italy" post="(2) Bangladesh (1) Germany (1) Switzerland (1) Germany (2)"/>
 <result pre="Italy (1) Canada (2) Austria (1) Japan (1) Italy (2)" exact="Bangladesh" post="(1) Germany (1) Switzerland (1) Germany (2) Sweden (1)"/>
 <result pre="Canada (2) Austria (1) Japan (1) Italy (2) Bangladesh (1)" exact="Germany" post="(1) Switzerland (1) Germany (2) Sweden (1) Saudi Arabia"/>
 <result pre="Austria (1) Japan (1) Italy (2) Bangladesh (1) Germany (1)" exact="Switzerland" post="(1) Germany (2) Sweden (1) Saudi Arabia (1) the"/>
 <result pre="Japan (1) Italy (2) Bangladesh (1) Germany (1) Switzerland (1)" exact="Germany" post="(2) Sweden (1) Saudi Arabia (1) the Netherlands (1)"/>
 <result pre="Italy (2) Bangladesh (1) Germany (1) Switzerland (1) Germany (2)" exact="Sweden" post="(1) Saudi Arabia (1) the Netherlands (1) Canada (2)"/>
 <result pre="Bangladesh (1) Germany (1) Switzerland (1) Germany (2) Sweden (1)" exact="Saudi Arabia" post="(1) the Netherlands (1) Canada (2) Denmark (1) Norway"/>
 <result pre="(1) Switzerland (1) Germany (2) Sweden (1) Saudi Arabia (1)" exact="the Netherlands" post="(1) Canada (2) Denmark (1) Norway (1) Thailand (1)"/>
 <result pre="Switzerland (1) Germany (2) Sweden (1) Saudi Arabia (1) the" exact="Netherlands" post="(1) Canada (2) Denmark (1) Norway (1) Thailand (1)"/>
 <result pre="Germany (2) Sweden (1) Saudi Arabia (1) the Netherlands (1)" exact="Canada" post="(2) Denmark (1) Norway (1) Thailand (1) Iran (1)"/>
 <result pre="Sweden (1) Saudi Arabia (1) the Netherlands (1) Canada (2)" exact="Denmark" post="(1) Norway (1) Thailand (1) Iran (1) Sweden (1)"/>
 <result pre="Saudi Arabia (1) the Netherlands (1) Canada (2) Denmark (1)" exact="Norway" post="(1) Thailand (1) Iran (1) Sweden (1) Malaysia (1)"/>
 <result pre="(1) the Netherlands (1) Canada (2) Denmark (1) Norway (1)" exact="Thailand" post="(1) Iran (1) Sweden (1) Malaysia (1) Malaysia (1)"/>
 <result pre="Netherlands (1) Canada (2) Denmark (1) Norway (1) Thailand (1)" exact="Iran" post="(1) Sweden (1) Malaysia (1) Malaysia (1) Norway (1)"/>
 <result pre="Canada (2) Denmark (1) Norway (1) Thailand (1) Iran (1)" exact="Sweden" post="(1) Malaysia (1) Malaysia (1) Norway (1) India (1)"/>
 <result pre="Denmark (1) Norway (1) Thailand (1) Iran (1) Sweden (1)" exact="Malaysia" post="(1) Malaysia (1) Norway (1) India (1) UK (1)"/>
 <result pre="Norway (1) Thailand (1) Iran (1) Sweden (1) Malaysia (1)" exact="Malaysia" post="(1) Norway (1) India (1) UK (1) Egypt (1)"/>
 <result pre="Thailand (1) Iran (1) Sweden (1) Malaysia (1) Malaysia (1)" exact="Norway" post="(1) India (1) UK (1) Egypt (1) Belgium (1)"/>
 <result pre="Iran (1) Sweden (1) Malaysia (1) Malaysia (1) Norway (1)" exact="India" post="(1) UK (1) Egypt (1) Belgium (1) Epidemiological, etiological,"/>
 <result pre="Malaysia (1) Malaysia (1) Norway (1) India (1) UK (1)" exact="Egypt" post="(1) Belgium (1) Epidemiological, etiological, and diagnostic studies (75.6%)"/>
 <result pre="Malaysia (1) Norway (1) India (1) UK (1) Egypt (1)" exact="Belgium" post="(1) Epidemiological, etiological, and diagnostic studies (75.6%) predominate among"/>
 <result pre="diagnostic studies (75.6%) predominate among research arising from collaborations between" exact="China" post="and other countries across a range of research topics"/>
 <result pre="virus, receptors, PCR techniques, and immunological detection methods. In addition," exact="China" post="and Japan have collaborated to conduct clinical studies on"/>
 <result pre="PCR techniques, and immunological detection methods. In addition, China and" exact="Japan" post="have collaborated to conduct clinical studies on extracorporeal membrane"/>
 <result pre="support, potential antiviral therapeutics, and clinical features of patients. Furthermore," exact="China" post="has launched joint research projects with the US, Australia,"/>
 <result pre="of patients. Furthermore, China has launched joint research projects with" exact="the US," post="Australia, and Canada to study protective measures for postpartum"/>
 <result pre="has launched joint research projects with the US, Australia, and" exact="Canada" post="to study protective measures for postpartum women and newborns,"/>
 <result pre="Distribution As of March 8, all 31 provincial-level entities in" exact="China" post="have published COVID-19-related articles in Chinese journals. From the"/>
 <result pre="focus on treatment, prevention, etiology, and prognosis, ranking first in" exact="China" post="in terms of number of publications. In addition to"/>
 <result pre="COVID-19 Resulting from Research Collaborations by Provinces and Cities in" exact="China" post="Province/City No. Chinese Papers No. Inter-provincial Collaborative Papers Ratio"/>
 <result pre="Early epidemiological investigations have found that most COVID-19 patients in" exact="China" post="had a history of travel to Wuhan, as well"/>
 <result pre="24,727 on March 8, 2020. Specifically, the worst-affected countries were" exact="the US," post="Spain, Italy, Germany, and China. The number of the"/>
 <result pre="risk of SARS-CoV-2 transmission were Thailand, Cambodia, Malaysia, Canada, and" exact="the US," post="based on the weekly simulated passengers' end-destination data for"/>
 <result pre="concentrated among West European countries, such as the UK (39%)," exact="France" post="(24%), and Germany (15%) before the implementation of the"/>
 <result pre="European countries, such as the UK (39%), France (24%), and" exact="Germany" post="(15%) before the implementation of the travel ban in"/>
 <result pre="travel of infectious COVID-19 cases from Wuhan to cities throughout" exact="China" post="before the quarantine was expected to result in a"/>
 <result pre="of transmission, and protecting the susceptible population. In addition, Singapore," exact="the US," post="the UK, and other countries have also taken active"/>
 <result pre="affected areas to reduce movement and increase personal protection in" exact="China" post="in the early stages of the COVID-19 outbreak. (5)Global"/>
 <result pre="of COVID-19 transmission have been implemented. In addition to China," exact="the US" post="Health Community has reviewed and updated protocols developed for"/>
 <result pre="quarantine periods and tracing close contacts of confirmed cases. Discussion" exact="China" post="Has Initiated COVID-19-Related Research in Considerable Scope and Depth"/>
 <result pre="China Has Initiated COVID-19-Related Research in Considerable Scope and Depth" exact="China" post="has made great contributions to scientific progress related to"/>
 <result pre="scope and depth. The early stages of the outbreak in" exact="China" post="provided a large number of cases for scientific research"/>
 <result pre="and sequenced the viral genome on January 12, 2020. Furthermore," exact="China" post="shared its diagnosis and treatment strategies worldwide, actively participated"/>
 <result pre="the SARS epidemic in 2003, the scientific research capability of" exact="China" post="has demonstrated great qualitative progress, promoting more virus-related research"/>
 <result pre="been published in English or Chinese. In addition to China," exact="the US," post="Canada, and European countries also carried out scientific research"/>
 <result pre="prevention and control during the recent outbreak. European countries and" exact="Japan" post="carried out epidemiological studies before the outbreak based on"/>
 <result pre="reached a consensus on strategic direction and cultivated scientific cooperation.73" exact="China" post="and the US have established cooperative networks with European"/>
 <result pre="consensus on strategic direction and cultivated scientific cooperation.73 China and" exact="the US" post="have established cooperative networks with European and Southeast Asian"/>
 <result pre="of broad-spectrum drugs for the treatment of coronaviral infections.74 For" exact="China" post="in particular, acceleration of research aimed at the clinical"/>
 <result pre="above general suggestions, there are some other specific efforts that" exact="China" post="must undertake. Regional differences in previous studies reflect the"/>
 <result pre="and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan," exact="China" post="in 2020: a correlational analysisJ.Â Travel Med.27202013 8ChengV.C.C.WongS.C.ChenJ.H.K.YipC.C.Y.ChuangV.W.M.TsangO.T.Y.SridharS.ChanJ.F.W.HoP.L.YuenK.Y.Escalating infection"/>
 <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci." exact="China" post="Life. Sci.502020258269 32RothanH.A.ByrareddyS.N.The epidemiology and pathogenesis of coronavirus disease"/>
</results>
